Stem Cell Reports,
Journal Year:
2023,
Volume and Issue:
18(8), P. 1686 - 1700
Published: July 6, 2023
Human
induced
pluripotent
stem
cell
(hiPSC)-derived
neuronal
networks
on
multi-electrode
arrays
(MEAs)
provide
a
unique
phenotyping
tool
to
study
neurological
disorders.
However,
it
is
difficult
infer
cellular
mechanisms
underlying
these
phenotypes.
Computational
modeling
can
utilize
the
rich
dataset
generated
by
MEAs,
and
advance
understanding
of
disease
mechanisms.
existing
models
lack
biophysical
detail,
or
validation
calibration
relevant
experimental
data.
We
developed
in
silico
model
that
accurately
simulates
healthy
MEAs.
To
demonstrate
potential
our
model,
we
studied
derived
from
Dravet
syndrome
(DS)
patient
with
missense
mutation
SCN1A,
encoding
sodium
channel
NaV1.1.
Our
revealed
dysfunctions
were
insufficient
replicate
vitro
DS
phenotype,
predicted
decreased
slow
afterhyperpolarization
synaptic
strengths.
verified
changes
patient-derived
neurons,
demonstrating
utility
predict
Stem Cell Reports,
Journal Year:
2021,
Volume and Issue:
16(9), P. 2182 - 2196
Published: July 29, 2021
Micro-electrode
arrays
(MEAs)
are
increasingly
used
to
characterize
neuronal
network
activity
of
human
induced
pluripotent
stem
cell
(hiPSC)-derived
neurons.
Despite
their
gain
in
popularity,
MEA
recordings
from
hiPSC-derived
networks
not
always
full
potential
respect
experimental
design,
execution,
and
data
analysis.
Therefore,
we
benchmarked
the
robustness
MEA-derived
patterns
ten
healthy
individual
control
lines,
uncover
comparable
phenotypes.
To
achieve
standardization,
provide
recommendations
on
design
With
such
MEAs
can
be
as
a
reliable
platform
distinguish
(disease-specific)
In
conclusion,
show
that
powerful
robust
tool
functional
phenotypes
networks,
an
important
resource
advance
hiPSC
field
toward
use
for
disease
phenotyping
drug
discovery.
Frontiers in Genetics,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 6, 2022
The
mitochondrial
DNA
(mtDNA)
m.3243A>G
mutation
is
one
of
the
most
common
pathogenic
mtDNA
variants,
showing
complex
genetics,
molecular
mechanisms,
and
phenotypes.
In
recent
years,
prevention
mtDNA-related
diseases
has
trended
toward
precision
medicine
strategies,
such
as
preimplantation
genetic
diagnosis
(PGD)
replacement
therapy
(MRT).
These
techniques
are
set
to
allow
birth
healthy
children,
but
clinical
implementation
relies
on
thorough
insights
into
genetics.
genotype
phenotype
vary
greatly
from
mother
offspring,
which
compromises
counseling
for
disease.
This
review
first
systematically
elaborate
characteristics
mutation,
genetics
relationship
between
them,
well
related
influencing
factors
potential
strategies
preventing
perceptions
will
provide
clarity
clinicians
providing
patients.
EMBO Reports,
Journal Year:
2023,
Volume and Issue:
24(4)
Published: March 6, 2023
Abstract
Mitochondrial
DNA
(mtDNA)
diseases
are
multi‐systemic
disorders
caused
by
mutations
affecting
a
fraction
or
the
entirety
of
mtDNA
copies.
Currently,
there
no
approved
therapies
for
majority
diseases.
Challenges
associated
with
engineering
have
in
fact
hindered
study
defects.
Despite
these
difficulties,
it
has
been
possible
to
develop
valuable
cellular
and
animal
models
Here,
we
describe
recent
advances
base
editing
generation
three‐dimensional
organoids
from
patient‐derived
human‐induced
pluripotent
stem
cells
(iPSCs).
Together
already
available
modeling
tools,
combination
novel
technologies
could
allow
determining
impact
specific
distinct
human
cell
types
might
help
uncover
how
mutation
load
segregates
during
tissue
organization.
iPSC‐derived
also
represent
platform
identification
treatment
strategies
probing
vitro
effectiveness
gene
therapies.
These
studies
potential
increase
our
mechanistic
understanding
may
open
way
highly
needed
personalized
therapeutic
interventions.
Progress in Biomedical Engineering,
Journal Year:
2023,
Volume and Issue:
5(3), P. 032002 - 032002
Published: April 18, 2023
Abstract
In
vitro
neuronal
models
have
become
an
important
tool
to
study
healthy
and
diseased
circuits.
The
growing
interest
of
neuroscientists
explore
the
dynamics
systems
increasing
need
observe,
measure
manipulate
not
only
single
neurons
but
populations
cells
pushed
for
technological
advancement.
this
sense,
micro-electrode
arrays
(MEAs)
emerged
as
a
promising
technique,
made
cell
culture
dishes
with
embedded
micro-electrodes
allowing
non-invasive
relatively
simple
measurement
activity
cultures
at
network
level.
past
decade,
MEAs
popularity
has
rapidly
grown.
MEA
devices
been
extensively
used
mainly
derived
from
rodents.
Rodent
on
employed
investigate
physiological
mechanisms,
effect
chemicals
in
neurotoxicity
screenings,
model
electrophysiological
phenotype
networks
different
pathological
conditions.
With
advancements
human
induced
pluripotent
stem
(hiPSCs)
technology,
differentiation
adult
donors
became
possible.
hiPSCs-derived
develop
patient-specific
platforms
characterize
pathophysiological
test
drugs,
paving
way
towards
personalized
medicine.
review,
we
first
describe
technology
information
that
can
be
obtained
recordings.
Then,
give
overview
studies
which
combination
(i.e.
rodent
2D
three-dimensional
(3D)
cultures,
organotypic
brain
slices,
3D
organoids)
biomedical
research,
including
physiology
studies,
disease
modeling,
drug
testing.
We
end
by
discussing
potential,
challenges
future
perspectives
providing
some
guidance
choice
device,
experimental
design,
data
analysis
reporting
scientific
publications.
Advanced Science,
Journal Year:
2023,
Volume and Issue:
10(20)
Published: April 23, 2023
Abstract
The
electrophysiological
technology
having
a
high
spatiotemporal
resolution
at
the
single‐cell
level
and
noninvasive
measurements
of
large
areas
provide
insights
on
underlying
neuronal
function.
Here,
complementary
metal‐oxide
semiconductor
(CMOS)‐microelectrode
array
(MEA)
is
used
that
uses
236
880
electrodes
each
with
an
electrode
size
11.22
×
µm
covering
wide
area
5.5
5.9
mm
in
presenting
detailed
single‐cell‐level
neural
activity
analysis
platform
for
brain
slices,
human
iPS
cell‐derived
cortical
networks,
peripheral
neurons,
organoids.
Propagation
pattern
characteristics
between
regions
changes
synaptic
propagation
into
compounds
based
time‐series
patterns,
classification
single
DRG
neuron
firing
patterns
compound
responses,
axonal
conduction
to
anticancer
drugs,
network
activities
transition
organoids
are
extracted.
This
using
CMOS‐MEA
provides
new
understanding
basic
mechanisms
circuits
vitro
ex
vivo,
neurological
diseases
drug
discovery,
toxicity
assessment.
Cell Reports,
Journal Year:
2024,
Volume and Issue:
43(3), P. 113883 - 113883
Published: March 1, 2024
Phosphomannomutase
2-congenital
disorder
of
glycosylation
(PMM2-CDG)
is
a
rare
inborn
error
metabolism
caused
by
deficiency
the
PMM2
enzyme,
which
leads
to
impaired
protein
glycosylation.
While
presents
with
primarily
neurological
symptoms,
there
limited
knowledge
about
specific
brain-related
changes
deficiency.
Here,
we
demonstrate
aberrant
neural
activity
in
2D
neuronal
networks
from
PMM2-CDG
individuals.
Utilizing
multi-omics
datasets
3D
human
cortical
organoids
(hCOs)
derived
individuals,
identify
widespread
decreases
glycosylation,
highlighting
as
key
pathological
feature
PMM2-CDG,
well
mitochondrial
structure
and
abnormal
glucose
PMM2-deficient
hCOs,
indicating
disturbances
energy
metabolism.
Correlation
between
enzymatic
hCOs
symptom
severity
suggests
that
level
enzyme
function
directly
influences
manifestations.
These
findings
enhance
our
understanding
perturbations
associated
offering
insights
into
underlying
mechanisms
potential
directions
for
therapeutic
interventions.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 21, 2024
Abstract
The
cellular
mechanisms
underlying
axonal
morphogenesis
are
essential
to
the
formation
of
functional
neuronal
networks.
We
previously
identified
autism-linked
kinase
NUAK1
as
a
central
regulator
axon
branching
through
control
mitochondria
trafficking.
However,
(1)
relationship
between
mitochondrial
position,
function
and
(2)
downstream
effectors
whereby
regulates
remain
unknown.
Here,
we
report
that
recruitment
synaptic
boutons
supports
collateral
branches
stabilization
rather
than
in
mouse
cortical
neurons.
deficiency
significantly
impairs
metabolism
ATP
concentration,
upregulation
is
sufficient
rescue
null
neurons
vitro
vivo.
Finally,
found
mitochondria-targeted
microprotein
BRAWNIN.
Our
results
demonstrate
exerts
dual
during
its
ability
distribution
metabolic
activity.